Each year, Canadian Breast Cancer Foundation makes critical new investments in innovative and relevant research, advocacy and education initiatives, thanks to the incredible generosity of our committed community of volunteers and donors. Canadian Breast Cancer Foundation is the largest non-governmental funder of breast cancer research in Canada and one of the largest in the world. The Canadian Breast Cancer Foundation is committed to allocating donor dollars responsibly to maximize the impact of our work. Each year, we aim to grow our investments in the cause while keeping costs of fundraising and administration as low as possible. Working together last year, we raised an impressive $22 million across Ontario, to fund research, education and advocacy initiatives.
*Reflects funds spent on cause-related work
*These statements reflect an unaudited financial summary of Ontario Region only. The Canadian Breast Cancer Foundation is audited on a national basis. For audited national financial statements, please see below.
Starting in Fiscal 2012 all national revenues and costs were allocated proportionality to regions and are reflected in this report, including Corporate Programs.
**Grants are presented net of monies returned by grantees due to project cost savings.
***Good Works Index is Total Cause-Related Work divided by the sum of Total Expenses plus Total Cause-Related Work.
Audited National Financial Statements
The above Income Statement reflects the Ontario Region only. The Canadian Breast Cancer Foundation is audited on a pan-Canadian basis.
To view our most recent audited financial statements, select the year below:
Annual T3010 Returns
To demonstrate compliance with federal tax laws, registered charities must file a Registered Charity Information Return (T3010) with the Canada Revenue Agency each year. The T3010 and the Audited Financial Statement serve two different purposes so figures may differ between statements. The Foundation follows Canada Revenue Agency procedures to complete the T3010.
View the Foundation's annual T3010 Returns